Literature DB >> 19125369

Sex determines the influence of smoking and gene polymorphism on glutathione peroxidase activity in erythrocytes.

Tine Halsen Malling1, Torben Sigsgaard, Helle Raun Andersen, Lone Frischknecht, Yoji Deguchi, Lars Skadhauge, David Sherson, Gert Thomsen, Jesper Baelum, Jacob Krabbe Pedersen, Øyvind Omland.   

Abstract

OBJECTIVE: Glutathione peroxidase 1 (GPX1) is one of the major oxidative enzymes. Our aim was to characterize factors influencing its activity and to determine whether or not the activity is associated with asthma.
MATERIAL AND METHODS: Serum selenium concentration was measured, GPX1 polymorphisms were genotyped and smoking history was obtained in a Danish population-derived case-base cohort of 1,191 subjects designed to evaluate risk factors for asthma. GPX1 activity was measured in 134 male and 164 female subjects equally distributed according to genotype of GPX1. Among these subjects, 82 (28 %) had doctor-diagnosed asthma.
RESULTS: The average serum selenium concentration was too low for optimal enzyme activity (mean (SE), 83.4 (0.76) ng/mL). GPX1 activity in men was lower than in women, 52.6 (0.66) and 56.4 (0.59) U/g protein, respectively (p<0.001). In men, activity was positively associated with serum selenium concentration (p = 0.005) and negatively associated with both active smoking (p = 0.009) and exposure to environmental tobacco smoke (p = 0.02). In women, activity was associated with genotypes with 59.2 (1.4), 56.0 (1.4) and 54.2 (1.4) U/g protein in the homozygote wild-type, the heterozygote and the homozygote variant type, respectively (p = 0.001). Doctor-diagnosed asthma was unrelated to GPX1 activity in either sex.
CONCLUSION: Determinants for activity in the oxidative enzyme GPX1 show marked differences between the sexes, but the activity is not associated with asthma. Sex ought to be taken into consideration when analysing the activity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125369     DOI: 10.1080/00365510802632155

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

Review 1.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

2.  Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.

Authors:  Yumie Takata; Alan R Kristal; Irena B King; Xiaoling Song; Alan M Diamond; Charles B Foster; Carolyn M Hutter; Li Hsu; David J Duggan; Robert D Langer; Helen Petrovitch; James M Shikany; Thomas L Vaughan; Johanna W Lampe; Ross L Prentice; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-15       Impact factor: 4.254

Review 3.  SEXUAL DIMORPHISM IN SELENIUM METABOLISM AND SELENOPROTEINS.

Authors:  Lucia A Seale; Ashley N Ogawa-Wong; Marla J Berry
Journal:  Free Radic Biol Med       Date:  2018-03-21       Impact factor: 7.376

Review 4.  Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.

Authors:  Edith Lubos; Joseph Loscalzo; Diane E Handy
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

5.  Brain region- and sex-specific transcriptional profiles of microglia.

Authors:  Kelly Barko; Micah Shelton; Xiangning Xue; Yvette Afriyie-Agyemang; Stephanie Puig; Zachary Freyberg; George C Tseng; Ryan W Logan; Marianne L Seney
Journal:  Front Psychiatry       Date:  2022-08-24       Impact factor: 5.435

6.  DNA damage and oxidative stress response to selenium yeast in the non-smoking individuals: a short-term supplementation trial with respect to GPX1 and SEPP1 polymorphism.

Authors:  E Jablonska; S Raimondi; J Gromadzinska; E Reszka; E Wieczorek; M B Krol; A Smok-Pieniazek; M Nocun; M Stepnik; K Socha; M H Borawska; W Wasowicz
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.